DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /PI3K/Akt/mTOR PathwayPI3K/Akt/mTOR Pathway
  5. /GSK-3GSK-3
  6. /ElraglusibElraglusib
Chemical structure of CAS 1034895-42-5

Elraglusib

In Stock•Starting at $33 for 5 mg•Purity ≥ 98%
CAS No.1034895-42-5
MDL No.N/A
MFC22H13FN2O5
MW404.30
InChI KeyFARXPFGGGGLENU-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$33In Stock
10 mg98%$54In Stock
25 mg98%$83In Stock
50 mg98%$136In Stock
100 mg98%$231In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1034895-42-5
Product NameElraglusib

Biological Targets

GSK3B

Associated Conditions

sarcoma·metastasis·non-Hodgkins lymphoma·bone neoplasm·malignant glioma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer.

Molecular cancer therapeutics • Vol. 13, Issue 2 • 2014
PMID: 24327518PMC: PMC3956125DOI: 10.1158/1535-7163.MCT-13-0681

From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.

Journal of medicinal chemistry • Vol. 52, Issue 7 • 2009
PMID: 19338355PMC: PMC2665923DOI: 10.1021/jm801317h

Adenosine triphosphate-derived nucleotide formation in the presence of ethanol.

Biochemical pharmacology • Vol. 25, Issue 16 • 1976
PMID: 9088DOI: 10.1016/0006-2952(76)90185-4

Documentation

Similar Products

  • 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione

    CAS No.603288-22-8

  • Enzastaurin

    CAS No.170364-57-5

  • 1H-pyrrole-2,5-dione, 3-(1-methyl-1H-indol-3-yl)-4-(1-methyl-6-nitro-1H-indol-3-yl)-

    CAS No.125313-92-0

  • Ruboxistaurin

    CAS No.169939-94-0

  • Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-

    CAS No.162652-95-1

  • Vinflunine Ditartrate

    CAS No.194468-36-5

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact